CVIR Endovascular · 2022 · 13 citations · 20 references
MedicineCardiologySurgeryCardiothoracic SurgeryInterventional CardiologyVascular SurgeryArterial InterventionsBalloon AngioplastyCoronary AngioplastyEndovascular SurgeryPercutaneous Coronary InterventionVascular Lesion TreatmentBailout AngioplastyBalloon Inflation PressureCulprit Lesion RevascularizationFemoropopliteal DiseaseFemoropopliteal InterventionFemoropopliteal RevascularizationPrimary PatencyTarget Lesion Revascularization
PURPOSE: To compare the impact of Chocolate and conventional balloons on vessel preparation in percutaneous transluminal angioplasty. MATERIALS AND METHODS: This single-center retrospective study included 111 endovascular therapy consecutive cases of femoropopliteal lesions using drug-coated balloon strategy with a 1:1 pre-dilation balloon diameter between February 2020 and August 2021, divided into the Chocolate percutaneous transluminal angioplasty (n = 48) and conventional (n = 63) groups. Before the availability of Chocolate balloons in Japan (December 2020), a standard semi-compliant or non-compliant balloon was used for vessel preparation. The primary endpoint was rate of severe dissection after pre-dilatation. Secondary endpoints were angiographic percent diameter stenosis, bailout stent rate, primary patency rate, and freedom from target-lesion-revascularization rate at six months. RESULTS: There was no significant difference in patient and lesion characteristics. The procedural characteristics comprised balloon length 90 ± 37 and 149 ± 95 mm (P = 0.004) and inflation pressure 11 ± 3 and 16 ± 7 atm (P < 0.001) in the Chocolate and conventional groups, respectively. Regarding primary endpoint, rates of severe dissection were 4.2% and 25% (P = 0.003); regarding secondary endpoints, percent diameter stenosis was 18 ± 15% and 20 ± 17% (P = 0.409), and the rate of bailout stenting was 2.1% and 15.9% (P = 0.016) in the Chocolate and conventional groups, respectively. The primary patency rates at six months were 89.1% and 85.2% (P = 0.670), and freedom from target-lesion-revascularization rate at six months was 100% and 92.8% (P = 0.691) in the Chocolate and conventional groups, respectively. CONCLUSION: Chocolate percutaneous transluminal angioplasty balloons reduce the rate of severe dissection while maintaining a sufficient dilatation effect during drug-coated balloon vessel preparation.
20
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Lars Norgren, William R. Hiatt, John Dormandy et al. · Journal of Vascular Surgery · 2007 · 8.2K citations · Full text
Medicine, Cardiology, Surgery +15
Victor Aboyans, Jean‐Baptiste Ricco, Marie-Louise Bartelink et al. · European Heart Journal · 2017 · 3.3K citations · Full text
Medicine, Cardiology, Surgery +17
Gunnar Tepe, John R. Laird, Peter A. Schneider et al. · Circulation · 2014 · 667 citations · Full text